PDF is committed to using your funds efficiently to support our mission. To see how your funds are spent, visit our financial information page.
More than 30 online seminars are now available for you to view! Topics include: nutrition, legal issues, nonmotor symptoms, medications in the pipeline and more.
Featured Creativity and Parkinson's Artist
View the Gallery:
PDF Press Releases
Parkinson's Disease Foundation Announces $1 Million for Novel Studies Into Parkinsonís
- Jul 07 2011
(New York, NY) The Parkinson’s Disease Foundation (PDF) is pleased to announce awards totaling more than $1 million for 11 novel investigator-initiated research projects designed to understand the cause(s) of and find a cure for Parkinson’s disease.
Investigator-driven projects are a core piece of PDF’s philosophy to empower the community – of scientists, clinicians, people with Parkinson’s and health care professionals – to find creative solutions benefitting the seven to 10 million people worldwide living with Parkinson’s. The projects are funded through two key programs: the International Research Grants program and the Research Fellowships program, which both seek to encourage novel ideas by respectively funding “high-risk/high-reward” projects and supporting scientists in the early stages of their careers.
A review committee that was chaired by Robert Burke, M.D., and included PDF’s Scientific Director, Stanley Fahn, M.D., chose the 11 projects, which range from basic science investigations of the cellular mechanisms that underlie the disease, to studies of potential new therapies. They also include ideas that may lead to symptomatic relief for the people who are living with Parkinson’s today.
For example, Parkinson’s research has typically focused on dopamine and its role in an area of the brain called the substantia nigra. Elena Vazey, Ph.D., of the Medical University of South Carolina in Charleston, SC, will use her research fellowship to cast a wider net, studying the role of norepinephrine released from brain stem neurons and its impact on the brain as a whole. Initial research suggests that changes in norepinephrine in the brain may contribute to changes in cognition, sleep and mood in Parkinson’s. Dr. Vazey’s investigations may help us to better understand the impact of brain norepinephrine upon Parkinson’s and the potential of norepinephrine-targeted therapies to treat the disease.
Her fellow awardees, Sarah B. Berman, M.D., Ph.D., and Edward Burton, M.D., D.Phil., of the University of Pittsburgh in Pittsburgh, PA, are using their International Research Grant to investigate a more popular topic, the role of the mitochondria (the power plant of the cell) in Parkinson’s. But their approach is unique. They will look for clues about the mitochondria by observing their movements in transparent zebrafish. By recording the motion of mitochondria as they migrate within the dopamine neurons and axons of a living animal, Dr. Berman and Dr. Burton hope to yield new insights into the role of the mitochondria in Parkinson’s.
PDF Executive Director, Robin Anthony Elliott commented on the nature of this year’s projects, “Time is of the essence for people with Parkinson’s. Part of our responsibility to the community is to provide promising scientists with opportunities to pursue creative strategies to understanding the disease. Each of this year’s research projects, in its own way, represents an innovative approach to solving Parkinson’s. We look forward to seeing how they progress. ”
Thomas Shiftan, M.D., a PDF research advocate who was part of the review committee noted, “After seeing first-hand the scientific debate among some of the world’s leading Parkinson’s experts, I am hopeful that we are pursuing Parkinson’s from every angle possible. I am glad to play a role in PDF’s team – of researchers, advocates, clinicians and supporters – in making a difference for people living with Parkinson’s.”
International Research Grants | $825,000
Designed to promote innovative research projects that have high potential to significantly advance the knowledge of Parkinson’s.
Evaluating the Role of Mitochondrial Dynamics in Parkinson's Disease in an In Vivo Vertebrate Model: Real-Time Live Imaging of Mitochondrial Dynamics in Dopamine Neurons in Whole Zebrafish
Sarah Berman, M.D., Ph.D., and Edward Burton M.D., D.Phil., F.R.C.P.
University of Pittsburgh
Impact of Low- and High-Frequency Electrical Stimulation on the Inputs, Integrative Properties and Output of the Subthalamic Nucleus
Mark Bevan, Ph.D.
Telomere Biology in Patients with Incident Parkinson’s Disease*
Tobias Kurth, M.D., Sc.D., and Robert Y.L. Zee, Ph.D., M.P.H.
Brigham and Women’s Hospital
Identification of Neuroprotective Factors in Tobacco*
Leo J. Pallanck, Ph.D.
University of Washington
Small Aromatic Molecules as Novel Inhibitors of Alpha-Synuclein Aggregation
Daniel Segal, Ph.D.
Tel Aviv University, Israel
Identification of Genes for Parkinson's Disease in an Isolated Greek Community and a Greek Population Cohort
Georgia Xiromerisiou M.D., Ph.D., and Henry Houlden M.D., Ph.D., M.R.C.P.
University of Thessaly, Greece and University College London, England
Research Fellowships | $250,000
Aim to generate interest in Parkinson’s research and patient care among basic scientists and clinicians.
Functional Dissection of a Novel Dopaminergic Inhibitory Circuit in Parkinson's Disease
Jun Ding, Ph.D.
Harvard Medical School
The Regulation of Somatodendritic Dopamine Release*
James Maas, M.D., Ph.D.
University of California, San Francisco
Evaluating Pedunculopontine Nucleus Stimulation as a Treatment for L-DOPA- Resistant Gait Disorders in Advanced Parkinson's Disease
Abirami Muralidharan, Ph.D.
University of Minnesota
The Role of Parkin in Regulating Mitochondrial Dynamics and Homeostasis in Cortical and Dopaminergic Neurons
Victor Van Laar, Ph.D.
University of Pittsburgh
The Locus Coeruleus as a Substrate for Parkinsonian Cognitive Inflexibility
Elena Vazey, Ph.D.
Medical University of South Carolina
*Denotes second year of funding
About Parkinson’s Disease
Parkinson’s disease is a progressive neurological disorder that affects nearly one million people in the US and seven to 10 million people worldwide. Although promising research is being conducted, there is currently no cure for Parkinson’s.
About PDF Research
Central to the mission of the Parkinson’s Disease Foundation (PDF) is funding research of the highest caliber. In fiscal year 2011, PDF will contribute a total of $5.5 million towards Parkinson’s research programs, funding 40 scientific projects around the world. These include projects and mentored fellowships initiated by individual investigators from the global scientific grassroots community and collaborative projects being conducted by research teams at major institutions. Grants are reviewed by PDF’s Scientific Advisory Committee, which includes leading researchers, clinicians and people living with Parkinson’s who work as trained research advocates with PDF’s Parkinson’s Advocates in Research (PAIR) program. A full list of 2012 research projects appears below and is available on the PDF website at www.pdf.org/en/results_funded.
About the Parkinson’s Disease Foundation (PDF)
The Parkinson’s Disease Foundation® (PDF®) is a leading national presence in Parkinson’s disease research, education and public advocacy. We are working for the nearly one million people in the US who live with Parkinson’s by funding promising scientific research while supporting people living with Parkinson’s through educational programs and services. Since its founding in 1957, PDF has dedicated over $90 million to fund the work of leading scientists throughout the world and over $37 million to support national education and advocacy programs.
Source Date: Jul 07 2011